Venture-Backed Startups
130,792 companies with verified investor relationships.
Curocell is a Korean biotech company developing CAR-T cell therapies for cancers such as lymphoma and leukemia, as well as autoimmune conditions like lupus. Its lead therapy anbalcel (marketed as Limkato) received manufacturing/marketing approval, making it one of Korea's most advanced CAR-T-focused companies.
4 investors
Curoflow provides a white-label digital healthcare platform for care providers, combining booking, triage, electronic medical records, a patient portal, payments, and business support in one system. Built for the European market with local hosting and GDPR/PDL compliance, it serves clinics and larger care chains.
1 investor
Curology offers personalized prescription skincare, connecting customers with licensed dermatology providers who prescribe custom-strength formulas of up to three active ingredients to treat acne and other skin concerns. The service is direct-to-consumer, delivering prescribed treatments and non-prescription products based on an online skin consultation.
4 investors
Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes. The platform combines content-addressable storage with a containerized workflow engine and runs on major cloud providers and on premise.
0 investors
Curql is a collective of 160+ credit unions that jointly invest in fintech startups and runs Curql Accelerate, an accelerator program for fintech companies solving credit union challenges. It serves credit unions seeking access to and investment in financial technology.
1 investor
0 investors
1 investor
0 investors
Currence combines an AI data engine with expert analysts to convert thousands of sources into proprietary data, models, and insights on the energy and AI sectors. It serves power and utility leaders, developers, and investors, delivering research and forecasts through a platform and API embedded into their decision workflows.
2 investors
Currencycloud provides a global cross-border payment platform for businesses to collect, convert, and manage multi-currency transactions across 180+ countries. The service enables virtual wallets, named accounts, and same-day transfers in 35+ currencies for B2B customers worldwide.
9 investors
CurrencyFair is an online cross-border payment and foreign exchange service that enables customers to send international payments across 20+ currency corridors. The company serves individual and business customers globally with simplified foreign exchange transactions.
2 investors
Currensea is a UK travel card that links directly to a user's existing bank account via direct debit, letting travelers spend abroad in local currency without high FX fees and without opening a new account or managing a prepaid balance. It also offers co-branded travel debit cards that convert everyday spending into loyalty points and airline miles through partnerships with travel brands.
2 investors
0 investors
Fishbit makes smart monitoring and automation devices for aquariums, allowing users to track and control their tanks remotely through a mobile app.
1 investor
Mode operates EarnOS, a rewards and monetization engine that runs on mobile phones and pays users for their daily activities and screen time. The company runs an M&A-driven platform spanning consumer apps, device licensing (EarnPhone), media, and financial services, acquiring profitable app businesses and integrating them with EarnOS.
1 investor
Current is a mobile-first banking platform offering no-fee spending accounts and integrated financial services to everyday Americans. The company operates on a spend-based model powered by interchange fees and maintains proprietary core banking technology.
14 investors
Current Clinic operates a network of healthcare centers specializing in the diagnosis and treatment of atrial fibrillation and other cardiac arrhythmias. The company delivers cardiology services outside traditional hospital settings to reduce costs and improve access to care.
1 investor
Current Foods produces plant-based and biotech-derived seafood products, including raw tuna and smoked salmon alternatives, designed to compete on flavor, nutritional profile, cost, and supply reliability. The company targets consumers seeking sustainable seafood options without sacrificing taste or health benefits.
3 investors
Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings. It works with health systems and global pharmaceutical companies to expand patient access to high-cost treatments outside traditional hospital settings.
3 investors
0 investors
Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.
3 investors
Current Tools manufactures over 100 tools for electrical contractors, including cable pullers, conduit benders, knockout sets, and jobsite storage. Most products are made on-site in the United States and come with a two-year warranty.
1 investor
1 investor
Currents is a dashboard, reporter, and test orchestrator focused on Playwright, used to debug, monitor, and speed up Playwright tests in CI. It targets software development and QA teams, offering features like rule-based automation, integrations (GitHub, Slack, Jira), crash-resilient reporting, smart test orchestration, and an MCP server for AI agents.
1 investor